The provision of clean injecting equipment is not very common in Europe, with the existence of syringe programmes in this setting reported by 5 countries, only 3 of which report the intervention’s actual implementation.

Multimedia:

Examples:

A recent announcement of the planned PNSP in 2 prisons in Canada is supported by an article to build support on developing harm reduction services in prison settings.

Federal government to uphold its commitment to a 'comprehensive, collaborative, compassionate and evidence-based approach to drug policy' (Government of Canada 2016), which includes harm reduction, by implementing PNSPs in consultation with correctional staff and people in prison. See more here.

See also:
(1) EMCDDA European drug report 2018,
(2)  Public health guidance on active case finding of communicable diseases in prison settings